New Delhi: The Indian Medical Association (IMA) on Friday said it has started a nodal centre, under the IMA PvPI (Pharmacovigilance Programme of India) Initiative, at the IMA headquarters here to enable its members to report adverse drug reactions.
Under the new initiative, the IMA members would be able to report adverse reactions to drugs, vaccines, medical devices, blood products and herbal products at IMA PvPI helpline 9717776514, which will function from 9AM-5.30PM on Monday to Friday. The IMA members may also call 18001803024.
Clinical trials only detect common adverse drug reactions as less than 500 human subjects are involved in any trial. Even one adverse drug reaction of medicine in 10,000 populations is considered as unsafe, according to a statement by the IMA.
Adverse drug reactions can be known or unknown, serious or non-serious due to drugs, vaccines, devices and blood products.
If any doctor finds their patient vomiting, suffering from stomach pain, excessive itching, rashes, a severe headache, or high fever after taking any drug report, they must report an adverse event to safeguard their patients, the statement said.
“Reporting even one adverse drug reaction can go a long way in safeguarding the overall health and safety of India’s 1.2 billion population,” according to Dr S S Agarwal, national president, IMA and Dr K K Aggarwal, honorary secretary general, IMA.
An adverse drug reaction (ADR) is an injury caused by taking a medication. ADRs may occur following a single dose or prolonged administration of a drug or result from the combination of two or more drugs.
Most adverse drug reactions are dose-related; others are allergic or idiosyncratic. Dose-related ADRs are usually predictable; ADRs unrelated to dose are usually unpredictable.